Advertisement

Pharmacy World and Science

, Volume 21, Issue 4, pp 152–157 | Cite as

Monitoring of Antimicrobial therapy by an integrated computer program

  • Santiago Grau
  • Josep Monterde
  • Alexia Carmona
  • Esther Salas
  • M¢nica Mar¡n
  • David Campany
  • Javier Mateu
Article

Abstract

Objective: To assess the impact of the setting‐up of a computer program designed by the Hospital Pharmacy Department as a tool that provides information for the antimicrobial therapy monitoring. To assess its influence on pharmaceutical costs. Material and method: The computer application for the follow‐up of antimicrobial treatments integrates information from the Pharmacy Department and the Microbiology Laboratory and selects all patients to whom some controlled antibiotic has been prescribed. The pharmacist reviews all the controlled antibiotic treatments, suggests any change to the physician if needed and quantifies the economic impact of the accepted interventions. Results: On average, 12.5% of controlled antibiotic treatments warranted a pharmaceutical intervention, and 92% of them were accepted. The most frequent interventions related to prescriptions were change of dosage and administration route and related to the disease were in respiratory and urinary tract infections. From the economic point of view, the accepted interventions represented a saving of 12,087,029 pesetas (83,359 $)/year, on average. Conclusion: The applied computer program resulted a useful tool for a clinical pharmacist to reach more correct antibiotical therapeutics and better cost‐effectiveness relation. It also helped to achieve favorable clinical outcomes.

Computer program Antimicrobial therapy Antibiotic control Interventions Pharmacy Cost 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sande MA, Chambers HF. Antimicrobial Agents: General Considerations. In: Goodman Gilman A, Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, eds. The Pharmacological Basis of Therapeutics, 9th de. New York: Mc Graw-Hill Companies Inc, 1995:1029-56.Google Scholar
  2. 2.
    Moellering RC. Principles of Anti-Infective Therapy. In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and practice of infectious diseases, 4th ed. New York: Churchill Livingstone Inc, 1995:199-212.Google Scholar
  3. 3.
    Woodward RS, Medoff G, Smith MD, Gray JL. Antibiotic cost-savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital. Am J Med 1987;83:817-23.PubMedGoogle Scholar
  4. 4.
    Bryan CS: Strategies to improve antibiotic use. Infectious Disease Clinics of North America 1989;3:723-34.PubMedGoogle Scholar
  5. 5.
    Grau S. Estudio de utilización de cefonicid (tesis doctoral). Barcelona: Universidad de Barcelona; 1994.Google Scholar
  6. 6.
    Inaranja MT, Paloma JM, Giráldez J, Iodate AJ, Hualde S. Computer-assisted antimicrobial-use monitoring. Am J Hosp Pharm 1986;43:664-70.PubMedGoogle Scholar
  7. 7.
    Pestotnik SL, Evans RS, Burke JP, Gardner RM, Classen DC. Therapeutic Antibiotic Monitoring: Surveillance Using a Computerized Expert System. Am J Med 1990;88:43-8.PubMedGoogle Scholar
  8. 8.
    Evans RS, Pestotnik SL, Burke JP, Gardner RM, Larsen RA, Classen DC. Reducing the duration of prophylactic antibiotic use through computer monitoring of surgical patient. DICP Ann Pharmacother 1990;24:351-4.Google Scholar
  9. 9.
    Pestotnik SL, Classen DC, Evans RS, Burke JP. Implementing Antibiotic Practice: Guidelines Through Computer-assisted Decision Support: Clinical and Financial Outcomes. Ann Intern Med 1996;124:884-90.PubMedGoogle Scholar
  10. 10.
    Peterson JP, Colocci VJ, Schiff SE. Using serum creatinine concentrations to screen for inappropriate dosage of renally eliminated drugs. Am J Hosp Pharm 1991;48:1962-4.PubMedGoogle Scholar
  11. 11.
    Goldberg DE, Baardsgaard G, Johnson M, Jolowsky CM, Shepherd M, Peterson CD. Computer-based program for identifying medication orders requiring dosage modification based on renal function. Am J Hosp Pharm 1991;48:1965-9.PubMedGoogle Scholar
  12. 12.
    Grau S, Saballs P, Drobnic L, Del Villar JA, Salas E, Monterde J, et al. Sustitución de cefamandol por cefonicid. Estudio prospectivo de utilización según protocolo. Rev Esp Quimioterap 1992;5:337-42.Google Scholar
  13. 13.
    Grau S, Del Villar A, Salas E, Drobnic L. Evolución de la prescripción de antibióticos restringidos en un hospital general. Farm Clin 1990;7:122-30.Google Scholar
  14. 14.
    Grupo de estudios de utilización de medicamentos de la Sociedad Española de Farmacia Hospitalaria. Estimación de la dosis diaria prescrita de antiinfecciosos en hospitales españoles. Farm Hosp 1994;18:15-21.Google Scholar
  15. 15.
    Acar JF, Goldstein FW. Trends in bacterial resistance to fluoroquinolones. Clin Infect Dis 1997;24(Suppl 1):S67-73.PubMedGoogle Scholar
  16. 16.
    Gomez-Lus R, Aisa ML, Uriel JA, Garcia C, Castillo J, Rubio MC. 1998. Increase of erythromycin resistance among 548 clinical strains of Streptococcus pneumoniae, abstr.E148, p.211. In Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, San Diego.Google Scholar
  17. 17.
    Jozefiak ET, Lewicki JE, Kozinn WP. Computer-assisted antimicrobial surveillance in a community teaching hospital. Am J Health-Syst Pharm 1995; 52:1536-40.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1999

Authors and Affiliations

  • Santiago Grau
  • Josep Monterde
  • Alexia Carmona
  • Esther Salas
  • M¢nica Mar¡n
  • David Campany
  • Javier Mateu

There are no affiliations available

Personalised recommendations